Surprisingly, genes that are most frequently mutated in AML, in particular FLT3 and NPM1, as well as some mutated genes reported previously, such as EZH2, KIT, and SF3B1, were not mutated in our study group [11,13]. The gene discussed is SF3B1; the disease is acute myeloid leukemia.